CEO of Biomarin Pharmaceutical, Inc. (BMRN, Financial) Jean Jacques Bienaime sells 3,000 shares of BMRN on 01/04/2013 at an average price of $52.24 a share.
Biomarin Pharmaceutical, Inc. has a market cap of $6.51 billion; its shares were traded at around $51.92 with and P/S ratio of 13.2.
For the complete insider trading history of BMRN, click here.
Biomarin Pharmaceutical, Inc. has a market cap of $6.51 billion; its shares were traded at around $51.92 with and P/S ratio of 13.2.
CEO Recent Trades:
- CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 01/04/2013 at the average price of 52.24. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 0.61% since.
- CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/31/2012 at the average price of 48.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 6.79% since.
- CEO Jean Jacques Bienaime sold 17,000 shares of BMRN stock on 12/27/2012 at the average price of 48.37. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 7.34% since.
- CEO Jean Jacques Bienaime sold 9,000 shares of BMRN stock on 12/21/2012 at the average price of 48.57. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 6.9% since.
- CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/12/2012 at the average price of 50. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 3.84% since.
Directors and Officers Recent Trades:
- EVP, Technical Operations Robert Baffi sold 20,000 shares of BMRN stock on 01/03/2013 at the average price of 53. Robert Baffi owns at least 100,413 shares after this. The price of the stock has decreased by 2.04% since.
- Director Richard A Meier sold 10,000 shares of BMRN stock on 01/02/2013 at the average price of 51.25. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 1.31% since.
- VP, Human Resources Mark Wood sold 10,415 shares of BMRN stock on 12/17/2012 at the average price of 49.17. Mark Wood owns at least 25,646 shares after this. The price of the stock has increased by 5.59% since.
- Director Richard A Meier sold 5,000 shares of BMRN stock on 12/11/2012 at the average price of 49.71. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 4.45% since.
- Director Richard A Meier sold 5,000 shares of BMRN stock on 11/29/2012 at the average price of 49.17. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 5.59% since.
For the complete insider trading history of BMRN, click here.
